This other transaction agreement for prototype is for an FDA cleared diagnostic assay able to differentiate between bacterial and viral infection in human clinical samples.

Other Transaction IDV Awarded Last action

Contract number
W911SR2490016
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$25,542,916.90
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Defense Joint Program Executive Office for Chemical and Biological Defense awarded an Other Transaction Agreement for Prototype to Cepheid on September 16, 2024, with a ceiling of $25,542,916.90. This OT IDV sits outside the FAR and supports development of an FDA-cleared diagnostic assay capable of differentiating between bacterial and viral infection in human clinical samples. Cepheid, headquartered in Sunnyvale, California, specializes in molecular diagnostic systems and rapid infectious disease testing through its GeneXpert platform, bringing established capability in point-of-care molecular diagnostics and federal healthcare supply relationships across the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and Defense Logistics Agency. The agreement funds prototype development toward regulatory clearance for a dual-pathogen diagnostic tool, supporting the Joint PEO's chemical and biological defense mission to expand rapid diagnostic capability for clinical differentiation of infection type.

Transactions

Action Obligated Date
Funding Only Action P00009 · This effort is to develop a food and drug administration (FDA) cleared $3,454,787
Funding Only Action P00008 · This effort is to develop a food and drug administration (FDA) cleared diagnostic assay able to differentiate between bacterial and viral infection in human… $1,077,647
Funding Only Action P00007 · This effort is to develop a food and drug administration (FDA) cleared $2,382,535
Funding Only Action P00006 · This effort is to develop a food and drug administration (FDA) cleared diagnostic assay able to differentiate between bacterial and viral infection in human… $1,315,639
Funding Only Action P00005 · This effort is to develop a food and drug administration cleared diagnostic assay able to differentiate between bacterial and viral infection in human… $173,720
Funding Only Action P00004 $1,058,272
Funding Only Action P00003 $800,000
Funding Only Action P00002 $1,012,333
Funding Only Action P00001 · This effort is to develop a food and drug administration (FDA) cleared diagnostic assay able to differentiate between bacterial and viral infection in human… -$434,633
Original award $1,433,201

Quick answers

Who was awarded contract W911SR2490016?

W911SR2490016 was awarded to Cepheid by ACC Aberdeen Proving Ground (Army Contracting Command) on September 16, 2024.

How much is contract W911SR2490016 worth?

W911SR2490016's own ceiling is $25,542,917.

Which agency awarded contract W911SR2490016?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR2490016, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR2490016 competed?

The extent of competition for W911SR2490016 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV